Late-onset clozapine-induced agranulocytosis in a young woman with paranoid schizophrenia

Anuhya Vinayaka, Shubha Sheshadri, Sharath Madhyastha, Ganesh Shetty, Charan Reddy

Research output: Contribution to journalArticlepeer-review


Treatment of schizophrenia has taken so many turns, and adverse effects of the drugs still continue to remain as a hurdle in the management. Clozapine is considered to be the better promising drug in the treatment of paranoid schizophrenia with minimal side effects. Clozapine-induced agranulocytosis is one adverse event that troubles clinicians, and it requires a vigilant eye to look for the signs. In the present study, the authors discuss a case which has developed agranulocytosis in the later stages of clozapine treatment.

Original languageEnglish
Pages (from-to)140-141
Number of pages2
JournalJournal of Pharmacology and Pharmacotherapeutics
Issue number4
Publication statusPublished - 01-10-2020

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmacology (medical)


Dive into the research topics of 'Late-onset clozapine-induced agranulocytosis in a young woman with paranoid schizophrenia'. Together they form a unique fingerprint.

Cite this